# Morris Miller

> Morris Miller is a startup investor at Xenex (San Antonio). See 0 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Xenex](https://shizune.co/investors/profile/xenex-disinfection-services)
- Location: San Antonio, United States
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/millermorris/

Morris Miller is a startup investor at Xenex in San Antonio. Under Morris Miller's leadership, Xenex has become a world leader in automated room disinfection. Through the use of Xenon technology and innovative hospital disinfection protocols, the company has helped hospitals achieve significant infection reduction results. As CEO, Morris is responsible for the company’s overall business strategy andoversight of day-to-day operations.Originally from San Antonio, TX, Morris is a graduate of the Dedman School of Law at Southern Methodist University, The University of Texas at Austin, and Phillips Exeter Academy. He is the founder of Sequel and Cutstone Ventures, which invests in/acts as an advisor to numerous start-ups such as Inventables, Adometry, and Golfballs.com. He started Curtis Hill Publishing, the first company to publish Texas case law on CD-ROM, and he was also the co-founder and President/CEO of Rackspace (NYSE: RAX). Morris is a member of APIC, BioMed SA, and ACG Central Texas.

## About Xenex

VC Fund · San Antonio, United States

Xenex is offering an effective approach to reducing the incidence of healthcare-associated infections.The Xenex mission is to save lives and reduce suffering by destroying deadly microorganisms that can cause hospital-acquired infections (HAIs). Xenex’s Pulsed Xenon Full Spectrum™ UV Disinfection Solution reduces the bacterial load oftenassociated with an increased risk for HAIs. Since its commercial launch in June 2010, Xenex devices are now included in infection control protocols in almost three hundred hospitals throughout the U.S.Xenex was founded in 2009 and headquartered in San Antonio, Texas.

5 contacts available at Xenex.

| Name | Title | Profile |
| --- | --- | --- |
| Morris Miller | CEO | https://shizune.co/investors/profile/morris-miller |
| Brian Cruver | Co-Founder | https://shizune.co/investors/profile/brian-cruver |
| Julie Stachowiak | Co- Founder & Chief Epidemiologist | https://shizune.co/investors/profile/julie-stachowiak |
| Mark Stibich | Co-Founder, Chief Scientific Officer & Speaker | https://shizune.co/investors/profile/mark-stibich |
| Paul Froutan | Chief Operating Officer & Chief Financial Officer | https://shizune.co/investors/profile/paul-froutan |

## FAQ

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co